UNSPSC 41122415: Centrifugal bioseparation crystals

Crystal beads utilized during blood centrifugation to entrap fibrin and facilitate bioseparation of sample

UNSPSC 41122415 Centrifugal bioseparation crystals is a Commodity code that encompasses specialized reagents, particles, and synthetic biological materials used in laboratory sample preparation, analysis, and surveillance workflows—including microbiome capture particles, oligonucleotides for sequencing and viral testing, synthetic viral controls, and qPCR reagents for wastewater and genomic surveillance. State and local procurement activity under this code is dominated by public health agencies and state laboratories conducting wastewater surveillance, newborn screening, and genomic epidemiology work. The Colorado Department of Public Health and Environment (CDPHE) Laboratory Services Division is a repeat buyer, issuing multiple sole-source procurements for Ceres Nanosciences microbiome particles ($3.5 million), Integrated DNA Technologies reagents and oligonucleotides (initial contract $650,000, modified to $1.7 million), Qiagen wastewater surveillance reagents and instruments ($3.14 million), Standard BioTools genomic systems and reagents ($2.3 million plus $1 million for reagents), and Twist Bioscience synthetic viral controls ($2.3 million). The Texas General Land Office has solicited water quality monitoring and analysis services under the Beach Watch Program (IFB 7643LP, due April 10, 2026), while the State of California has posted multiple laboratory equipment and supply procurements (March–April 2026) for forensic evidence collection consumables, microplate sealing equipment, and general laboratory supplies. The City of Palm Bay, Florida issued an ITB for laboratory testing services across water, wastewater, and groundwater facilities (ITB 19-ITB-26, due March 13, 2026), and Santa Clara County sought proposals for a Public Health Lab Information Management System replacement (RFI, due April 22, 2026).

Activity concentrates in Colorado, California, and Texas, with secondary activity in Florida. The recent procurement window (February through June 2026) shows heavy reliance on sole-source justifications tied to proprietary reagent compatibility, federal grant requirements, and validated workflows; the Colorado CDPHE contracts in particular cite exclusive manufacturing rights, CDC designation, and integration with existing instrumentation as grounds for sole-source awards. Vendors named include Ceres Nanosciences, Integrated DNA Technologies, Qiagen, Standard BioTools, Twist Bioscience, and multiple forensic and environmental testing contractors. Most procurements are structured as fixed-term agreements (typically five years) with annual or per-sample pricing rather than lump-sum awards, and several include set-aside or disadvantaged-enterprise documentation requirements (VetHUB in Texas, CBE in California). The code shows consistent buying patterns around infectious-disease surveillance, environmental compliance testing, and forensic operations, with emphasis on proprietary reagent platforms and specialized analytical consumables rather than commodity chemicals.